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An Intrinsic Adenylate Kinase Activity
Regulates Gating of the ABC Transporter CFTR
Nikaido, 1990). However, the mechanisms coupling en-
zymatic activity to substrate transfer remain controver-
sial (Higgins, 2001).
Christoph Randak and Michael J. Welsh
Howard Hughes Medical Institute
Departments of Internal Medicine and Physiology
and Biophysics This uncertainty is highlighted in CFTR. CFTR forms
an anion channel in which Cl flows passively in eitherRoy J. and Lucille A. Carver College of Medicine
University of Iowa direction across a membrane, following its electrochem-
ical gradient. When the R domain is phosphorylated,Iowa City, Iowa 52242
ATP interacts with the NBDs to gate the channel (for
reviews see Gadsby and Nairn, 1999; Hanrahan et
al., 2003; Sheppard and Welsh, 1999). As with otherSummary
ABC transporters, CFTR can function as an ATPase
(Mg2·ATP  H2O→Mg2·ADP  Pi). While under someCystic fibrosis transmembrane conductance regulator
(CFTR) is an anion channel in the ATP binding cassette experimental conditions it is possible to obtain low-level
channel gating without enzymatic activity, when ATP(ABC) transporter family. Like other ABC transporters,
it can hydrolyze ATP. Yet while ATP hydrolysis influ- alone is present, ATP hydrolysis regulates activity. How-
ever, it has long seemed puzzling that an ATPase activityences channel gating, it has long seemed puzzling that
CFTR would require this reaction because anions flow would be required for CFTR Cl channel function. For
example, in CFTR, ATP hydrolysis does not fuel ionpassively through CFTR. Moreover, no other ion chan-
nel is known to require the large energy of ATP hydroly- movement, and the number of ions flowing through the
channel bears no fixed stoichiometric relationship tosis to gate. We found that CFTR also has adenylate
kinase activity (ATP  AMP ←→ADP  ADP) that regu- ATP hydrolysis. In addition, gating of other ion channels
is not known to require the large energy input of ATPlates gating. When functioning as an adenylate kinase,
CFTR showed positive cooperativity for ATP sug- hydrolysis. These considerations raised the question of
whether an enzymatic activity that does not require hy-gesting its two nucleotide binding domains may dimer-
ize. Thus, channel activity could be regulated by two drolysis might gate CFTR. One possibility is adenylate
kinase. Adenylate kinases catalyze the phosphotransferdifferent enzymatic reactions, ATPase and adenylate
kinase, that share a common ATP binding site in the reaction Mg2·ATP  AMP ←→ Mg2·ADP  ADP (Yan
and Tsai, 1999). Whereas the standard transformedsecond nucleotide binding domain. At physiologic nu-
cleotide concentrations, adenylate kinase activity, Gibbs energy of the ATPase reaction is large (32 kJ/
mole), that of adenylate kinase reactions is close torather than ATPase activity may control gating, and
therefore involve little energy consumption. zero, and the equilibrium constant under physiologic
conditions never varies far from 1 (Alberty and Gold-
berg, 1992).Introduction
In previous studies, we found that a recombinant
CFTR-NBD2 polypeptide hydrolyzed ATP (Randak et al.,CFTR belongs to the ABC transporter family and con-
tains its defining features, two nucleotide binding do- 1997). But when AMP was also present, the NBD2 poly-
peptide functioned as an adenylate kinase. The adenyl-mains (NBDs) and two membrane-spanning domains
(MSDs) (Higgins, 2001; Riordan et al., 1989). In addition, ate kinase inhibitor, P1,P5-di(adenosine-5) pentaphos-
phate (Ap5A) abolished both ATPase and adenylateCFTR has a unique regulatory (R) domain. In ABC trans-
porters, the NBDs are the most highly conserved feature. kinase activities. Based on these considerations, we
hypothesized that CFTR possesses adenylate kinaseEach of these domains contains an ATP-interacting re-
gion consisting of a phosphate binding loop (P loop or activity that regulates channel function.
Walker A motif) connected to a  sheet core and an 
helix. This structure is conserved in other nucleotide Results
binding proteins including RecA, the F1-ATPase, Ras,
and adenylate kinases (Higgins et al., 1986; Smith and An Isolated CFTR-NBD2 Polypeptide Has ATPase
Rayment, 1996). Indeed, an early model predicting the and Adenylate Kinase Activity
structure of ABC transporter NBDs used the known We found that an isolated NBD2 polypeptide comprising
structure of adenylate kinase as a guide (Hyde et al., CFTR amino acids 1208–1399 converted ATP to Pi and
1990). ADP (Figures 1A and 1B), indicating ATPase activity.
Members of the ABC transporter family translocate a Adding AMP abolished Pi production and increased ADP
wide diversity of substances across membranes (Dassa, generation. These data indicated that AMP switched
2003; Holland and Blight, 1999). In ABC transporters, NBD2 from an ATPase (Mg2·ATP H2O→Mg2·ADP
the NBDs can hydrolyze ATP, and in some cases these Pi) to an adenylate kinase (Mg2·ATP  AMP ←→
proteins spend the energy of ATP hydrolysis to pump Mg2·ADPADP). They also reveal that within the physi-
substances across membranes, actively importing or ologic range of ATP concentrations, enzymatic activity
exporting substrate (Bishop et al., 1989; Davidson and or ATP turnover rate, was similar whether the NBD2
polypeptide functioned as an ATPase or as an adenylate
kinase. These results are consistent with our earlier*Correspondence: michael-welsh@uiowa.edu
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revealed the qualitative aspects of enzymatic activity
(for reviews see Holland and Blight, 1999; Schneider
and Hunke, 1998). Nevertheless, enzymatic activity
could differ in an intact ABC transporter for several rea-
sons, including interactions with membrane domains
and/or dimerization of the NBDs. Therefore, to test the
hypothesis that full-length CFTR possesses adenylate
kinase activity that gates the channel, we asked if Ap5A
would inhibit current. Ap5A is a well-characterized inhibi-
tor of adenylate kinases, but it does not inhibit ATPases
(Figure 2A) (Feldhaus et al., 1975; Lienhard and Secem-
ski, 1973). We added Ap5A to the cytosolic surface of
excised, inside-out membrane patches containing large
numbers of CFTR Cl channels and found that it revers-
ibly inhibited current in a dose-dependent manner (Fig-
ure 2B). Ap5A did not support current on its own (Figure
2B, legend).
Half-maximal current inhibition occurred with 13 M
Ap5A (Figure 2C), a concentration 6 times lower than
the 75M ATP concentration used in this study; a similar
inhibitor to substrate ratio has been observed in other
adenylate kinases (Feldhaus et al., 1975). Maximal Ap5A
concentrations reduced current 50%. Lack of com-
plete current inhibition might have two explanations.
ATP binding at one NBD alone might support some
channel activity. Earlier studies that reduced or blocked
ATP binding to NBD2 found reduced gating (Cotten and
Welsh, 1998; Gunderson and Kopito, 1995; Ikuma and
Welsh, 2000; Zeltwanger et al., 1999). However, the de-
gree of current reduction varied between approximately
50% and 90% in the different experimental ap-
proaches. Alternatively, Ap5A binding to one NBD might
support some ATP-dependent gating through the other
NBD. In either case, failure of high Ap5A concentrations
to totally inhibit current suggests it did not block all ATP
binding sites.
Ap5A Inhibits Current by Binding
an ATP-Site and an AMP-Site
Ap5A inhibits adenylate kinases by binding two distinct
sites; an adenosine at one end of Ap5A binds the ATP
binding site of adenylate kinases, and an adenosine at
Figure 1. ATPase and Adenylate Kinase Activities of Recombi- the other end attaches to an AMP binding site (Figure
nant NBD2 2A shows a hypothetical model for Ap5A binding CFTR
(A) ATPase activity measured as Pi release. Asterisk indicates p  NBD2) (Lienhard and Secemski, 1973; Mu¨ller and Schulz,
0.001 by paired t test.
1992). When bound, Ap5A mimics a phosphoryl transfer(B) Enzymatic activity measured as ADP release from ATP. Lines
transition state. If CFTR functions as an adenylate kinaseare fit of data to Michaelis-Menten equation. For the control, Km
and if Ap5A inhibition involves mechanisms similar towas 922 	 89 M and Vmax was 15.5 	 0.3 nmol/(min·mg MBP-
NBD2). With 1 mM AMP, Km was 170 	 16 M and Vmax was 21.7 	 those that inhibit adenylate kinases, then the effect on
0.4 nmol/(min·mg MBP-NBD2). C. Phosphotransfer was measured CFTR should meet four key predictions.
as ATP formation. Line is fit of data to Michaelis-Menten equation First, ATP should compete with Ap5A. To test for compe-with a Km of 233 	 27 M and Vmax of 9.1 	 0.2 nmol/(min·mg MBP- tition, we asked whether Ap5A alters the ATP dose-NBD2). All data are initial rates and values are means 	 range from
response relationship. In the absence of Ap5A, increasing2–3 experiments.
ATP concentrations increased current, and consistent
with previous studies the data fit the Michaelis-Menten
equation (Figure 2D) (Szellas and Nagel, 2003). Ap5Astudies (Randak et al., 1997, 1999). To confirm adenylate
kinase activity, we tested the reversibility of the reaction. shifted the relationship between ATP concentration and
current to the right without altering maximal current. AnWhen we added ADP, the isolated NBD2 polypeptide
produced ATP (Figure 1C). Eadie-Hofstee plot (Figure 2E) yielded a curve convex
to the left indicating the presence of two nonidentical,
independent ATP binding sites (or alternatively, negativeThe Adenylate Kinase Inhibitor Ap5A
Inhibits CFTR Cl Currents cooperativity) (Levitzki and Koshland, 1976). The line in
Figure 2E is fit to an equation with two independent ATPPrevious studies of isolated NBDs from ABC transport-
ers (with both identical and nonidentical NBDs) have binding sites with Ap5A increasing the apparent ATP Km
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at one of the two sites. Thus, Ap5A inhibited current by the AMP site (Figure 3C). Half-maximal current stimula-
tion occurred at 73 	 20 M AMP (Figure 3D). As wecompeting with ATP, probably at one of two ATP-sites.
Second, AMP should inhibit the effect of Ap5A (Lien- discuss below, this concentration is in the range of cyto-
solic AMP concentrations and is similar to Km values forhard and Secemski, 1973). Figure 2F shows that AMP
attenuated Ap5A-mediated inhibition. an NBD2 polypeptide (see Figure 7C) and other adenyl-
ate kinases (Byeon et al., 1995; Font and Gautheron,Third, inhibition should depend on the length of the
phosphate linker because the number of phosphates 1980; Ito et al., 1980; Okajima et al., 1993).
To test the mechanism by which AMP stimulated cur-determines the distance between the two adenosines,
and thereby sterically constrains their ability to simulta- rent, we examined the relationship between ATP con-
centration and current and found that AMP lowered theneously bind the two distinct sites (Feldhaus et al., 1975;
Lienhard and Secemski, 1973). Ap5A caused more inhibi- apparent Km for ATP (Figure 3E). An Eadie-Hofstee plot
(Figure 3F) revealed a pattern diagnostic (a curve convextion than Ap4A (with four phosphates), while Ap3A and
Ap6A (with three and six phosphates) inhibited minimally to the right) of positive two-site cooperativity for ATP.
Finding positive cooperativity indicates that AMP in-(Figure 2G). This pattern is equivalent to that in adenylate
kinases (Feldhaus et al., 1975; Lienhard and Secemski, duced a different gating mechanism with an ATP-depen-
dent interaction between two distinct ATP sites, likely1973), and indicates that to inhibit CFTR, both adenosine
groups must bind within a defined distance. NBD1 and NBD2. The observation that maximal current
was the same under both conditions suggests a rate-Fourth, the AMP binding site should be specific for
an adenine base. Adenylate kinases are usually very limiting step common to both ATPase and adenylate
kinase-dependent gating.specific with respect to the base in their nucleotide mo-
nophosphate binding site, but not to the nucleotide tri-
phosphate binding site (for review see Yan and Tsai, ATP, AMP, and Ap5A Govern
1999). For example, GTP can be a phosphate donor, the Rate of Channel Opening
but GMP cannot substitute for AMP as a phosphate The AMP-induced changes indicated that AMP should
acceptor. In ABC transporters, including CFTR, the alter the channel opening rate, the same gating step
NBDs prefer ATP but other nucleotides such as GTP are controlled by ATP alone. To test this, we studied mem-
accepted with reduced affinity (Anderson et al., 1991; brane patches containing single CFTR Cl channels;
Schneider and Hunke, 1998). Moreover, in CFTR, GTP Figure 4A shows data from one single-channel patch,
prevented photolabeling with 8-azido-ATP (Travis et al., and Figure 4B shows average properties from multiple
1993), and in an NBD2 polypeptide, ATP and GTP com- patches. Reducing cytosolic ATP concentration from 1 mM
peted for binding, but GMP could not bind in place of to 75 M decreased open state probability (Po) by pro-
AMP (Randak et al., 1996, 1999). We found that Ap5A longing the interburst interval (i.e., by reducing the rate
inhibited currents generated by GTP (Figure 2H), sug- of opening into a burst of activity) without altering burst
gesting Ap5A competition at the ATP/GTP binding site. duration. These data agree with earlier studies (for re-
In addition, we predicted that if the two sites had differ- view see Sheppard and Welsh, 1999). AMP increased
ent base specificities, then the asymmetrical dinucleo- Po by reducing the interburst interval, whereas Ap5A had
tide polyphosphate Gp5A (P1-(5-guanosyl) P5-(5-aden- the opposite effect. Neither compound changed burst
osyl) pentaphosphate) would inhibit current, but Gp5G duration or single-channel current amplitude. Thus,
(P1,P5-di(guanosine-5) pentaphosphate) would not. Ex- ATP, AMP, and Ap5A all act on the same gating step,
perimental testing confirmed these predictions (Fig- the rate of channel opening.
ure 2I). Adenylate kinase activity involves two binding sites,
Taken together, these data indicate that Ap5A inhibits an ATP site and an AMP site. Could the two sites be the
CFTR by simultaneously binding two sites, an AMP site ATP binding sites of NBD1 and NBD2? Five observations
and an ATP site. For the AMP site, they suggest that indicate the answer is no. (1) AMP induced positive two-
the site is selective for an adenine base and does not site cooperativity for ATP. This result indicates that in
bind nucleotides with a guanine base. For the ATP site, the presence of AMP, two ATP molecules bind simulta-
they suggest that ATPase and adenylate kinase enzy- neously to influence gating. Thus, AMP must bind to a
matic activities share a common ATP binding site. We different site. (2) Finding that ATP and AMP both in-
further test these hypotheses below. crease the opening rate, but AMP does so only in the
presence of ATP suggests that ATP and AMP do not
share a common binding site. (3) Previous studies andAMP Alters ATP-Dependent Channel Activity
To learn whether gating can be controlled by adenylate our data indicated that the ATP sites in CFTR NBDs
accepted nucleotides with a guanine base (Anderson etkinase activity or only ATPase activity, we added AMP.
If CFTR has adenylate kinase activity, AMP should bind al., 1991; Randak et al., 1996; Travis et al., 1993). How-
ever, the AMP site did not accept GMP, indicating aand alter gating (Figure 3A). On the other hand, if CFTR
were only an ATPase, then AMP would have no effect binding site different from those that bind ATP. (4) Ap5A
only inhibited 50% of the current. As we discussedor might inhibit if it competes with ATP binding. We
found that AMP did not stimulate current on its own above, this suggests that Ap5A left open an ATP site that
was available to bind ATP and support some channel(Figure 3, legend), but at intermediate ATP concentra-
tions, AMP reversibly increased current 20%–30% (Fig- activity. (5) Structural studies of other ABC transporter
NBDs suggest that two NBDs can form a dimer with theure 3B). Consistent with a previous report (Schultz et
al., 1995), at saturating ATP concentrations AMP elicited ribose oxygens of the two ATPs 34–37 A˚ apart (Hopfner
et al., 2000; Smith et al., 2002). Because in Ap5A boundno additional current. Stimulation was specific for AMP
versus GMP, further supporting the base specificity of to adenylate kinase the ribose oxygens are 16 A˚ apart
Cell
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Figure 2. Inhibition of CFTR Cl Current by Ap5A
(A) Model of Ap5A binding to NBD2.
(B) Representative time course of Cl current (I) from an excised, inside-out patch containing multiple CFTR channels. ATP and Ap5A were
present during times and at concentrations indicated by bars. For this and all other experiments, PKA was present throughout. With Ap5A
alone, current was  1% that obtained with ATP in same patch (n 
 9).
(C) Effect of Ap5A concentration on current ([ATP] 
 75 M). Half-maximal inhibition occurred at 13 	 4 M Ap5A and maximum current
reduction was 50 	 2%. Data are from 11 patches; n  4 for each point.
(D) Effect of ATP concentration on current in absence (control, black) and presence (blue) of 1 mM Ap5A. Because each patch contained a
different number of CFTR channels, all currents were normalized to the current obtained with 1 mM ATP under control conditions (I/I1 mM ATP).
Line for control data is fit of Michaelis-Menten equation using Km 
 42 	 2 M and maximal current (Imax) 
 1.03 	 0.01. Line for Ap5A data
is fit of equation for two nonidentical, independent sites, I 
 Imax,1·[ATP]/(Km,1[ATP]) Imax,2·[ATP]/(K m,2[ATP]), and Imax,1 of 0.51 	 0.08, Imax,2
of 0.50 	 0.07, Km,1 of 38 	 10 M, and Km,2 of 935 	 322 M. Data are from 27 patches; n 
 4 for each ATP concentration.
(E) Eadie-Hofstee plot of data shown in (D). Linear relationship for control data indicates pattern of no cooperativity. For the paired Ap5A data,
line is fit from (D) revealing shape of nonidentical, independent ATP sites or negative cooperativity.
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(Mu¨ller and Schulz, 1992), a similar dimeric structure in dent gating. First, they indicate that AMP and AMP-NH2
bind to a distinct AMP site independent of ATP, includingCFTR would not allow Ap5A binding to the two ATP
binding sites. Thus, we conclude that CFTR contains at physiologic ATP concentrations. Second, they sug-
gest that binding to the AMP site inhibits ATPase-depen-two ATP binding sites (NBD1 and NBD2) and an AMP
binding site that is different from the ATP sites. More- dent gating. This result agrees with our studies of an
NBD2 polypeptide in which AMP inhibited ATPase activ-over, the ATPase and adenylate kinase enzymatic activi-
ties share a common ATP binding site. ity. Third, they suggest when AMP binds, it enables
phosphotransfer (adenylate kinase activity) that contrib-
utes to the channel gating cycle. Thus, the data suggestATP:AMP Phosphotransfer Influences
that AMP switches the enzymatic activity involved inChannel Gating
gating from that of an ATPase to that of an adenylateThe experiments described above raised the question
kinase. At physiologic ATP concentrations, AMP doesof whether phosphotransfer from ATP to AMP was in-
not necessarily alter the amount of current; instead itvolved in gating, or whether AMP binding alone would
changes the mechanism by which that current is gener-suffice to explain the effects. To answer this question,
ated. Finding that maximal current generated by bothwe asked whether an AMP analog that cannot act as a
ATPase and adenylate kinase activities was similar sug-phosphate acceptor, AMP-NH2 (adenosine 5-mono-
gests the involvement of a common rate-limiting step.phosphoramidate, Figure 5A), would bind the AMP site
Our finding of a similar turnover rate for an NBD2 poly-and stimulate current. Figure 5B shows that AMP-NH2
peptide functioning as an ATPase or as an adenylatenot only failed to stimulate current, but instead it de-
kinase at physiologic ATP concentrations parallels thiscreased current. To learn whether inhibition occurred
conclusion. The explanation may relate to the sharedbecause AMP-NH2 bound to the AMP site, we asked
ATP binding site of the two enzymatic activities.whether ATP and AMP were competitive with its effects.
Like Ap5A, maximal AMP-NH2 concentrations inhibited
about 50% of the current (Figure 5C). Repeating the ADP Alters Channel Kinetics Consistent
with Adenylate Kinase ActivityAMP-NH2 dose-response curve at ATP concentrations
up to 10 mM did not alter the apparent Ki or maximal If CFTR has adenylate kinase activity, ADP should alter
channel activity through this readily reversible reactioncurrent reduction, indicating that ATP and AMP-NH2 did
not compete for a common binding site. In contrast, (Mg2·ATP  AMP ←→ Mg2·ADP  ADP). But if CFTR
only functions as an ATPase, we expect that the soleAMP reversed inhibition and increased the apparent Ki
for AMP-NH2 without changing maximal inhibition (Fig- effect of ADP would be inhibition by competition with
ATP. Testing this hypothesis is complicated, becauseure 5C). These data indicate that AMP-NH2 bound to the
AMP site and thereby inhibited gating produced by ATP ADP does compete with ATP, and it thereby reduces
channel opening rate and inhibits current (Aleksandrovalone (i.e., ATPase-dependent gating). Figure 5D shows
an example at saturating ATP concentrations. AMP-NH2 et al., 2001; Anderson and Welsh, 1992; Schultz et al.,
1995; Travis et al., 1993). However, because AMP in-inhibited ATPase-dependent gating, but subsequent ad-
dition of AMP competed with AMP-NH2 to restore cur- duces positive two-site cooperativity for ATP, we rea-
soned that ADP might promote positive cooperativity byrent. This result suggests that AMP induced a different
gating mechanism, adenylate kinase activity that sup- generating AMP through phosphotransfer. As previously
reported, ADP inhibited current (Figures 6A and 6B). Butported current. The 10-fold lower apparent affinity of
AMP-NH2 compared to AMP (Figures 5C and 3D) is con- it also induced striking positive cooperativity as revealed
by an Eadie-Hofstee plot (Figure 6C). These results aresistent with their relative binding affinities to glycogen
phosphorylase b (Menendez et al., 1985). Consistent consistent with the conversion of ADP to AMP, which
then generated positive cooperativity.with the conclusion that AMP-NH2 inhibited ATPase-
dependent gating as well as phosphotransfer, AMP-NH2 To test further whether phosphotransfer between two
ADP molecules was required, we studied ADP-NH2 (ade-reduced Po by altering the same gating step as ATP
and AMP but in the opposite direction; it prolonged the nylyl 5-phosphoramidate), an ADP analog that does
not allow phosphotransfer. Like ADP, ADP-NH2 inhibitedinterburst interval (Figure 5E).
These data together with results described above pro- current and competed with ATP (Figure 6D). But in con-
trast to ADP, ADP-NH2 failed to induce positive coopera-vide insight into the mechanisms of nucleotide-depen-
(F) AMP competition of Ap5A-dependent inhibition. Percentage inhibition was calculated from difference in current before and after adding
1 mM Ap5A ([ATP] 
 75 M). Asterisk indicates p  0.001 by t test; n 
 8 without AMP and n 
 10 with AMP from 4 patches.
(G) Effect of phosphate chain length on inhibition by diadenosine polyphosphates ([ATP] 
 0.3 mM; [ApnA] 
 0.5 mM). Data are percentage
inhibition compared to average of current immediately before and after ApnA addition. Data were from 7 patches; n  10 for each ApnA.
Asterisks indicate p 0.001 compared to Ap5A by one-way analysis of variance (ANOVA) followed by Tukey test. These diadenosine polyphos-
phates (0.5 mM) did not significantly stimulate current in absence of ATP (n 
 3 for each ApnA).
(H) GTP-stimulated current and competition with Ap5A. Left image shows representative current trace and right image shows average data.
Asterisk indicates p  0.001 by Student’s t test; n 
 6 with 1 mM GTP and n 
 7 with 0.1 mM GTP.
(I) Inhibition by dinucleotide pentaphosphates (Np5N) containing adenosine and guanosine moieties. Left image shows representative trace
and right image shows averages. Data are calculated from the difference in current before and after addition of Np5N ([ATP] 
 0.3 mM;
[Np5N] 
 0.5 mM). Asterisk indicates p  0.001 compared to Ap5A and Gp5A by ANOVA followed by Tukey test. Data are from 12 patches;
n  4 for each Np5N. These dinucleotide pentaphosphates added alone stimulated  2% of the current generated by an equal amount of
ATP (n 
 3–5 for each Np5N).
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Figure 3. Effect of AMP on CFTR Cl Cur-
rents
(A) Model of ATP and AMP binding to NBD2.
(B) Time course showing effect of 1 mM AMP
added at three different ATP concentrations.
AMP (1 mM) alone did not significantly stimu-
late current (n 
 5).
(C) Effect of 250 M AMP and 250 M GMP
on current. Top shows tracing and bottom
shows percentage increase. n 
 4. (D) Effect
of AMP concentration on Cl current ([ATP]

75 M). Data are increase in current relative
to that produced by 1 mM AMP in same ex-
periment. Line is Michaelis-Menten fit with Km
of 73	 20M and a relative maximal increase
of 1.08 	 0.07 times that produced by 1 mM
AMP. Data are from eight patches and n  4
for each AMP concentration.
(E) ATP-dependent current in absence (con-
trol, black) and presence (red) of 1 mM AMP.
Experiments were performed as shown in (B).
Data are from 26 patches with n  4 for each
ATP concentration. Data were normalized as
described in Figure 2D legend. Line for con-
trol data is fit to Michaelis-Menten equation
using Km of 40	 2 M and Imax of 1.03	 0.01.
In presence of AMP, line is fit to Hill equation
with Km of 28 	 1 M, Imax of 1.00 	 0.01, and
Hill coefficient of 1.60 	 0.07.
(F) Eadie-Hofstee plot of data from (E).
tivity (Figure 6E). Therefore, the surprising finding of NBD2 Mutations Disrupt ATPase and Adenylate
Kinase Activitiesan “inhibitor” (ADP) that induces positive cooperativity
supports the conclusion that adenylate kinase activity To assess further the NBD contribution to adenylate
kinase activity, we studied specific mutations. We mu-gates the channel.
Because the ATP site accepts nucleotides with a gua- tated the invariant Walker A Lys because it sits in the
P loop that forms the core of the ATP binding pocketnine base but the AMP site does not, we tested GDP.
GDP inhibited current without inducing cooperativity in both ABC transporters and adenylate kinases, and
its mutation disrupts catalytic activity of both enzymes(Figures 6F and 6G). Thus, inhibition resembled that
produced by ADP-NH2 and not ADP. Because the gua- (Byeon et al., 1995; Mu¨ller and Schulz, 1992; Ramjee-
singh et al., 1999). Because the ATPase and adenylatenine nucleotide does not bind to an adenylate kinase
AMP site, this result further supports the conclusion that kinase activities of CFTR share an ATP binding site, we
predicted that this mutation would disrupt both reac-phosphotransfer between two bound nucleotide di-
phosphates induced positive cooperativity. It also ar- tions. We also mutated the conserved Walker B Asp,
which coordinates the catalytic Mg2 in ABC transportergues that positive cooperativity is not some unusual
consequence of current inhibition. NBDs (Gaudet and Wiley, 2001; Hopfner et al., 2000;
Adenylate Kinase Regulates CFTR Gating
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Figure 4. Influence of AMP and Ap5A on Single-Channel Gating
(A) Example from one single-channel patch perfused on cytosolic surface with ATP, AMP and Ap5A. Studies were done at 75 M ATP because
at this concentration AMP produced its largest effects on current. Left images show example of 1 min of recording and mean Po. For illustration
purposes, traces were digitally low-pass filtered at 100 Hz. Right images show burst duration histograms and closed dwell time histograms.
Histograms were fit by single exponential functions (lines) and time constants are indicated (TB, mean burst duration; TIB, mean interburst
closed time).
(B) Average single-channel properties. n 
 5–9 membrane patches. Asterisks indicate p  0.05 compared to 75 M ATP alone using ANOVA
followed by Dunnett’s multiple comparison test.
Karpowich et al., 2001; Yuan et al., 2001). In addition, we Walker A and B motif mutations (K1250A and D1370N)
abolished both ATPase and adenylate kinase activitiesstudied a relatively common CF-associated mutation,
N1303K (Osborne et al., 1992); interestingly, two other (Figures 7A and 7B). In contrast, the N1303K variant only
modestly impacted ATP hydrolysis: Vmax was reducedmissense mutations at this site also cause CF. Crystal
structures of ABC transporter NBDs show that homolo- 50%, but Km showed little change (Figure 7A). How-
ever, this mutation eliminated ADP conversion to ATPgous asparagines lie in their helical subdomain and do
not contribute to the ATP binding pocket (Diederichs et (Figure 7B) and the AMP-induced increase in ADP pro-
duction (Figure 7C). These data indicate that the N1303Kal., 2000; Gaudet and Wiley, 2001; Hung et al., 1998;
Karpowich et al., 2001; Yuan et al., 2001). mutation primarily affected adenylate kinase activity
with only moderate effects on ATPase activity.When introduced into an NBD2 polypeptide, the
Cell
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Figure 5. Inhibition of CFTR Cl Currents by AMP-NH2
(A) Model of ATP and AMP-NH2 binding to NBD2.
(B) Time course of current during addition of ATP and AMP-NH2. AMP-NH2 alone did not significantly stimulate current (n 
 9).
(C) Effect of AMP-NH2 concentration on current. Currents (I ) were normalized to current level measured in absence of AMP-NH2. Data were
from 40 patches; n  4 for each point. Lines are fit of data to equation: I (%) 
 100  B·[AMP-NH2]/(Ki  [AMP-NH2]) using the following
values for apparent Ki (Ki) and maximal current reduction (B ): 1 mM ATP, 0.78 	 0.09 mM, and 47.0 	 1.5%; 3 mM ATP, 0.79 	 0.21 mM,
and 47.4 	 3.7%; 10 mM ATP, 0.83 	 0.13 mM, and 47.3 	 2.1%; 3 mM ATP plus 0.5 mM AMP, 5.97 	 1.54 mM, and 49.0 	 8.1%.
(D) Representative tracing of effect of AMP on current inhibition by AMP-NH2. Bars indicate presence of ATP, AMP-NH2, and AMP.
(E) Influence of AMP-NH2 on single-channel gating. See Figure 4 legend. Top shows 1 min of recording for each condition; bottom shows
data from 6 patches. Asterisks indicate p  0.05 by paired t test.
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Figure 6. Effect of Adenine Dinucleotides
on Current
(A) Representative tracing showing current
inhibition by ADP and ADP-NH2.
(B) Effect of ATP concentration on current in
absence (black) and presence of 1 mM ADP
(red). For all data in this figure, currents were
normalized as in Figure 2D. Control data were
fit to Michaelis-Menten equation using Km of
38 	 2 M and Imax of 1.04 	 0.01. Data in
presence of ADP were fit to Hill equation us-
ing Imax of 0.91 	 0.03, apparent Km of 1726 	
121 M, and Hill coefficient of 1.30 	 0.08.
Data are from 22 patches; n  4 for each
ATP concentration.
(C) Eadie-Hofstee plots of data in (B). Line
curved convex to right indicates positive co-
operativity.
(D) Effect of ATP concentration on current in
absence (black) and presence of 1 mM ADP-
NH2 (green). Lines were fit to Michaelis-
Menten equation; for control, Km was 43 	 3
M and Imax was 1.03 	 0.01; for ADP-NH2,
Imax was 0.96 	 0.02 and apparent Km was
228 	 16 M. Data are from 20 patches and
n  4 for each ATP concentration.
(E) Eadie-Hofstee plots of data in (D).
(F) Effect of ATP in absence (black) and pres-
ence of 1 mM GDP (blue). Lines were fit of
Michaelis-Menten equation. For control, Km
was 37 	 2 M and Imax was 1.02 	 0.01, and
for GDP, Imax was 0.99 	 0.02, and apparent
Km was 1309 	 80 M. Data are from 11
patches; n  4 for each ATP concentration.
(G) Eadie-Hofstee plot of data from (F).
We also made the corresponding mutations in CFTR of ATP, and agrees with our earlier finding that wild-type
and N1303A CFTR had the same ATP EC50 for currentand examined their effect on channel activity. The
Walker A mutations (K464A in NBD1 and K1250A in stimulation (Berger et al., 2002). These results, together
with the recombinant NBD2 and structural data de-NBD2) reduced the fraction of current at 75 M ATP
versus that at 1 mM (Figure 7D). These results are con- scribed above suggest that the N1303K mutation had
little consequence for the ATP binding site. In contrast,sistent with the previously reported rightward shifts in
the ATP dose-response curves and a reduction in ATP N1303K abolished the effects of AMP and Ap5A (Figures
7E and 7F). These results correspond with the NBD2binding and hydrolysis (Aleksandrov et al., 2002; Ander-
son and Welsh, 1992; Ramjeesingh et al., 1999; Vergani polypeptide data and suggest that this mutation affects
the AMP binding site and preferentially inhibits adenyl-et al., 2003). Mutating K1250 also abolished the stimula-
tory effect of AMP and the inhibitory effect of Ap5A, ate kinase activity. Thus, these data begin to discrimi-
nate between the ATPase and adenylate kinase effectswhereas K464A enhanced Ap5A inhibition (Figures 7E
and 7F). These differential effects suggest that NBD2, on channel activity.
and not NBD1, contains the adenylate kinase activity
that gates the channel. Results with the Walker B Asp Discussion
mutations (D572N in NBD1 and D1370N in NBD2) exactly
paralleled the P loop mutations (Figures 7D–7F), further Earlier work indicated that CFTR can function as an
ATPase and that hydrolysis contributes to channel gat-suggesting that adenylate kinase activity resides in
NBD2. ing (for reviews see Gadsby and Nairn, 1999; Hanrahan
et al., 2003; Sheppard and Welsh, 1999). Our data indi-We obtained different results with the N1303K muta-
tion. The fraction of current at 75 M ATP versus that cate that CFTR is also an adenylate kinase, and that its
enzymatic activity gates the channel. The results furtherat 1 mM was the same as in wild-type (Figure 7D). This
result suggests that N1303K did not alter the potency suggest that NBD2 harbors the adenylate kinase acti-
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Figure 7. Effect of NBD Mutations
(A–C) Enzymatic activity of an isolated NBD2.
(A) ADP formation by NBD2 polypeptide.
NBD2 was wild-type or contained K1250A,
D1370N, or N1303K mutations. In (A–C), data
are initial rates given as means 	 range of
2–9 experiments. Data for wild-type are the
same as in Figure 1 and are shown for compari-
son. Line for N1303K is fit using Michaelis-
Menten equation with Km of 625	 117M and
Vmax of 6.7 	 0.3 nmol/(min·mg MBP-NBD2).
(B) Adenylate kinase activity of NBD2 mea-
sured as ATP formation.
(C) Effect of AMP concentration on ADP for-
mation ([ATP]
 5 mM). Line for wild-type was
fit using Km of 59 	 10 M. ADP formation in
absence of AMP represents ADP production
by ATPase activity.
(D–F) Currents from wild-type and mutant
CFTR recorded from multichannel patches at
1 mM ATP and at 75 M ATP in absence and
presence of 1 mM AMP or 1 mM Ap5A. Data
are from 5 (wild-type, K464A, D572N), 9
(K1250A), 10 (D1370N), and 3 (N1303K) mem-
brane patches. Asterisks indicate p  0.05
compared to wild-type by ANOVA followed
by Dunnett’s multiple comparison test. NBD1
mutations are in gray bars, and crosshatched
bars represent NBD2 mutations.
(D) Percentage current at 75 M ATP relative
to that at 1 mM ATP.
(E) Percentage increase in current induced by
1 mM AMP addition ([ATP] 
 75 M).
(F) Percentage inhibition of current caused
by 1 mM Ap5A addition ([ATP] 
75 M).
vity that controls gating. In NBD2, both the ATPase NBDs shows the highest degree of sequence and struc-
ture variation (Ames et al., 1992; Gaudet and Wiley,and adenylate kinase activities share an ATP binding
site, but instead of releasing the -phosphate as in an 2001). Consistent with this conjecture, Asn1303 sits in
the NBD2 helical subdomain; mutating it abolished ade-ATPase, the adenylate kinase activity transfers the
-phosphate to an AMP molecule. nylate kinase but not ATPase activity in an NBD2 poly-
peptide, and abolished AMP and Ap5A effects on gating
without altering ATP potency. Alternatively, AMP mightRelationship between Adenylate Kinase
bind at the dimer interface between the two NBDs,Activity and NBD Structure
thereby enhancing interactions between the NBDs. WeHow is it that one protein (one NBD) is capable of func-
are not aware of other proteins that display two suchtioning both as an ATPase and as an adenylate kinase?
enzymatic activities. However, a structural comparisonComparing the crystal structures of ABC transporter
revealed similarities between the GTPase Ras and aNBDs and adenylate kinases provides some clues. Im-
nucleoside monophosphate kinase (UMP/CMP kinase)portantly, both proteins share a three-dimensional fold
despite 12% sequence identity, suggesting the possi-consisting of a phosphate binding loop connected to a
bility of similar enzymatic mechanisms (Kosloff and Sel- sheet core and an  helix (Higgins et al., 1986; Smith
inger, 2003).and Rayment, 1996). This structure binds ATP and most
likely comprises the ATP binding site that we found was
common to the ATPase and adenylate kinase activities Which Enzymatic Activity Gates CFTR In Vivo?
Finding that CFTR can function either as an ATPaseof CFTR. In adenylate kinases, the AMP binding site is
predominantly a helical structure, but it can show little or as an adenylate kinase raises the question, which
enzymatic activity gates the channel under physiologicsequence conservation between kingdoms (Diederichs
and Schulz, 1990; Mu¨ller and Schulz, 1992; Vonrhein et conditions? Cytosolic nucleotide concentrations will de-
termine the answer. Intracellular ATP concentrationsal., 1998). Although the AMP binding site in CFTR is
unknown, we speculate that it may lie in the helical have been measured from 1 to 11.7 mM in several cells
and tissues (Frederich and Balsch, 2002; Kennedy etsubdomain of NBD2. This portion of ABC transporter
Adenylate Kinase Regulates CFTR Gating
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al., 1999). Because these values lie well above the ATP bolic stress altered ratios of ATP, ADP, and AMP, or
Km’s for gating by both enzymatic activities, its concen- if nucleotide concentrations differed between the bulk
tration will not be the determining factor under basal cytosol and membrane microdomains, then reversibility
conditions. Instead, the AMP concentration will estab- of the reaction might help maintain channel activity. In
lish which reaction predominates. Intracellular AMP has this context, it is interesting that AMP may have an
been measured as 1%–6% of the ATP concentration, additional role; the metabolic sensor AMP-activated
and ADP as 10%–26% of the ATP concentration (Bozzi protein kinase can regulate CFTR by a different mecha-
et al., 1994; Malaisse and Sener, 1987; Olson et al., 1996; nism, phosphorylation of the C terminus that inhibits
Pucar et al., 2002; Zeleznikar et al., 1995). Therefore, the current (Hallows et al., 2000).
AMP concentration will lie between 10–700 M; these
concentrations support adenylate kinase activity as indi-
cated by the AMP Km of 73 	 20 M for CFTR gating. ATP and AMP Induce Conformational Changes
Thus, just as physiologic AMP concentrations support in the NBDs that Govern Transport
the enzymatic activity of other adenylate kinases in vivo Recent data have improved understanding of how ATP
(as discussed above they have similar AMP Km values), might influence ABC transporter structure. Studies of
these measurements suggest that CFTR will function as prokaryotic ABC transporters revealed positive cooper-
an adenylate kinase in vivo. ativity in the relationship between ATP concentration
The data showing that the adenylate kinase and and ATPase activity (Davidson et al., 1996; Liu et al.,
ATPase reactions share an ATP site also bears on this 1997). Although the consequences for function are un-
issue. When AMP binds to the neighboring site, hy- known, that discovery suggested that the two NBDs
drolytic release of the ATP -phosphate is prevented, interact. Supporting that conclusion, ATP binding in-
and instead the -phosphate is transferred to AMP. We duced physical associations between the two NBDs of
found that adding AMP switched enzymatic activity of several ABC transporters (Fetsch and Davidson, 2002;
an NBD2 polypeptide from ATPase to adenylate kinase. Hopfner et al., 2000; Janas et al., 2003; Moody et al.,
In addition, AMP-NH2 binding to the AMP site in CFTR 2002). A molecular explanation for how this might occur
inhibited gating produced by ATP alone (i.e., ATPase- came when the crystal structures of Rad50, BtuCD, and
dependent gating). MJ0796 NBDs revealed the two NBDs in a head-to-
We also considered that if NBD1 operated as an tail dimer clamping two nucleotides at the NBD-NBD
ATPase, gating might involve substantial ATP hydrolysis interface (Hopfner et al., 2000; Locher et al., 2002; Smith
even if NBD2 functioned predominantly as an adenylate et al., 2002). Each ATP was sandwiched between the
kinase. However, several recent studies show that while Walker A motif (the P loop) of one NBD and the signature
ATP binding to NBD1 is important for gating, in the intact LSGGQ motif of the other NBD. Those results suggested
protein this domain carries out little or no hydrolysis that ATP binding might cause NBD-NBD dimerization,
(Aleksandrov et al., 2002; Basso et al., 2003; Szabo et and that enzymatic activity and ADP production might
al., 1999). lead to dimer dissociation. However, interactions be-
Taken together, these observations suggest that ATP tween the two NBDs have not yet been linked to
binding to both NBDs influences CFTR gating, but in transport.
the presence of physiologic AMP concentrations the Our finding of positive cooperativity in ATP-depen-
predominant enzymatic reaction regulating channel ac- dent gating indicates that in the presence of AMP, the
tivity is probably adenylate kinase. This conclusion has two ATP binding sites (NBD1 and NBD2) interact to
important energetic implications. In the past, it has influence function. A common mechanism to cause coo-
seemed difficult to reconcile the huge energy expendi- perativity is dimerization, and based on the discussion
ture of ATP hydrolysis with the fact that CFTR transports above, it seems highly likely that in the presence of AMP,
Cl entirely passively and that no other ion channel is
ATP induced NBD1-NBD2 dimerization. We also showed
known to require the energy of ATP hydrolysis for gating.
that AMP increased the opening rate of single CFTR
Because adenylate kinase activity releases little if any
channels; this is the same gating step controlled by ATP.energy, our findings bring the energetics of CFTR ion
Therefore, we tentatively conclude that in the presencetransfer and gating in line with that of other ion channels.
of AMP, ATP-induced dimerization caused the channelEarlier studies of ATPase-dependent activity showed an
to open.asymmetric gating cycle, presumably driven by the free
After dimerization, adenylate kinase activity wouldenergy of ATP hydrolysis (Gunderson and Kopito, 1995;
produce two ADP molecules. Previous studies of otherIshihara and Welsh, 1997). Although the adenylate ki-
NBDs suggest that ADP might cause an NBD dimer tonase reaction is readily reversible, we expect that in
dissociate (Moody et al., 2002). Therefore, we speculatethe presence of ATP and AMP and negligible ADP this
that adenylate kinase activity will cause NBD1-NBD2enzymatic process could also drive asymmetric gating
dimer dissociation and channel closure. At that point,due to a concentration gradient between reactants and
one of two things might happen. ADP might leave itsproducts. In a somewhat similar manner, a transmem-
binding sites, followed by a new round of ATP and AMPbrane electrochemical gradient can drive an asymmetric
binding causing channel opening. Alternatively, adenyl-gating cycle in voltage-gated Clchannels (Richard and
ate kinase activity might use ADP to regenerate AMPMiller, 1990).
and ATP leading to NBD redimerization and channelAdenylate kinase activity intrinsic to CFTR may also
opening if ATP were bound at NBD1. Consistent withhave physiologic relevance because this is the only
this proposition, we found that ADP induced positiveknown reaction linking AMP with the ATP/ADP equilib-
rium in the cell. For example, if active transport or meta- cooperativity for ATP.
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Expression and Purification of Recombinant Wild-TypeOther Implications
and Mutant NBD2 PolypeptidesPerhaps other ABC transporters will also utilize adenyl-
A polypeptide corresponding to CFTR amino acids 1208–1399 fusedate kinase activity to govern transport. This might occur
to maltose binding protein (MBP-NBD2) was expressed, purified
if energy is not required for transport. Because hy- from soluble E. coli proteins, and characterized analytically as de-
drophobic substrates associate with membranes and scribed (Randak et al., 1997). HPLC and N-terminal amino acid se-
quence analysis of mutated proteins revealed only a single N-ter-some substrates are rapidly modified after transloca-
minal sequence corresponding to the N terminus of MBP. Aftertion, it is not clear whether all other ABC transporters
digestion with endoproteinase Lys-C, we identified the NBD2 frag-accumulate substrate above electrochemical equilib-
ments carrying the mutations by mass spectroscopy of each variant
rium. If transport were energetically neutral or downhill, protein. Fragments corresponding to peptides without the desired
adenylate kinase activity could suffice to control trans- mutation could not be detected. HPLC, Lys-C digestion, amino acid
port. In addition, adenylate kinase activity could provide sequencing, and mass spectroscopy were performed as described
(Randak et al., 1997).a physiologic mechanism to couple transport to the met-
abolic state of the cell, i.e., the relative amounts of ATP,
Assays of Enzymatic ActivitiesADP, and AMP. Thus, investigating adenylate kinase
The rate of ADP formation was measured continuously by monitor-
activity in other ABC transporters may shed light on the ing the decrease in absorption of NADH at 340 nm caused by ADP
still unresolved problem of how these proteins couple coupled to the pyruvate kinase and lactic dehydrogenase reactions
ATP binding and enzymatic activity to substrate translo- as described (Randak et al., 1997). ATPase activity was measured
as rate of release of inorganic phosphate at 0.5 mM ATP in thecation and the persistent controversy about transport
presence or absence of 1 mM AMP using the EnzChek phosphateenergetics (Higgins, 2001).
assay kit (Molecular Probes, Inc., Eugene, OR) as described (RandakThe knowledge that CFTR has adenylate kinase activ-
et al., 1997). The concentration of MBP-NBD2 employed in these
ity also provides a target for developing agonists and assays was varied between 0.10 and 0.64 mg/ml.
antagonists of potential value for therapy of CF and Adenylate kinase activity was measured as the rate of ATP forma-
tion as a function of ADP concentration following methods pre-other disorders that involve ABC transporters.
viously described (Fontanella et al., 1999). Nucleotide and 0.10–0.39
mg/ml wild-type or 0.45–0.90 mg/ml of mutant MBP-NBD2 were
incubated at 25C with 50 mM Tris-HCl, [pH 7.5], 100 mM KCl, 5 mMExperimental Procedures
MgCl2, 20 mM glucose, 0.5 mM NAD, 2 U/ml hexokinase, and 4
U/ml glucose-6-phosphate dehydrogenase (Sigma-Aldrich Corp.,Cells and Expression Systems for Wild-Type
St. Louis, MO) in 360 l. ATP formation resulted in an equimolarand Mutant CFTR
increase in NADH that was continuously measured as an increaseWild-type and mutant CFTR were transiently expressed in HeLa
in 340 nm absorbance. At end of the assay, we added 0.25 mM ATPcells using a hybrid vaccinia virus system or adenovirus vectors, as
to induce an immediate, maximal increase in absorbance to verifypreviously described (Ostedgaard et al., 2002; Sheppard et al.,
that the assay detected nascent ATP.1995).
Reagents
Gp5A was obtained from Jena Bioscience GmbH (Jena, Germany).Patch-Clamp Studies
All other nucleotides and bisubstrate inhibitors were from Sigma-We studied excised, inside-out membrane patches. The pipette (ex-
Aldrich Corp. ATP was added as the Mg2 salt. Gp5A, Ap3A, Ap4A,tracellular) solution contained, in mM: 140 N-methyl-D-glucamine,
Ap6A, and Gp5G were ammonium salts. Ap5A was used either as2 MgCl2, 5 CaCl2, 100 L-aspartic acid, and 10 N-2-hydroxyethyl
ammonium salt or as sodium salt with identical results.piperizine-N´-ethanesulfonic acid (HEPES), pH 7.3 with HCl. The bath
(intracellular) solution contained in mM: 140 N-methyl-D-glucamine,
Data Presentation3 MgCl2, 1 cesium ethylene glycol bis (2-aminoethyl ether) –
Data are presented as mean 	 SEM unless otherwise stated.N,N,N,N tetraacetic acid (CsEGTA), and 10 N-2-hydroxyethyl pip-
P values 0.05 were considered statistically significant.erizine-N-ethanesulfonic acid (HEPES), pH 7.3 with HCl. Following
patch excision, channels were activated with catalytic subunit of
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